awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28084046-2E1DD8CB-7047-4E5F-B26B-7FF9118201FC
Q28084046-2E1DD8CB-7047-4E5F-B26B-7FF9118201FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28084046-2E1DD8CB-7047-4E5F-B26B-7FF9118201FC
Hepatocellular carcinoma: Where there is unmet need
P2860
Q28084046-2E1DD8CB-7047-4E5F-B26B-7FF9118201FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28084046-2E1DD8CB-7047-4E5F-B26B-7FF9118201FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d8b99ef7f221f4bda9a2c2f72522841d28c178c
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.